VitalNext Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 8

VitalNext General Information

Description

Developer of innovative life science technology designed to offer health benefits to the aging population. The company's products build a bridge between the products and the market for consumer products that aid in living longer in a healthy way and provide preclinical and clinical development programs to generate value for the products, enabling people to stay aware of and enjoy healthy aging and to stay in good health for prolonged periods.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • J.H. Oortweg 19
  • 2333 CH Leiden
  • Netherlands
+31 071
Primary Industry
Other Consumer Non-Durables
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • J.H. Oortweg 19
  • 2333 CH Leiden
  • Netherlands
+31 071

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VitalNext Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 07-Oct-2020 Completed Generating Revenue
3. Early Stage VC 25-Feb-2016 Completed Generating Revenue
2. Grant 05-Nov-2013 $273K $1.98M Completed Startup
1. Early Stage VC 04-Jul-2013 $1.98M $1.98M Completed Startup
To view VitalNext’s complete valuation and funding history, request access »

VitalNext Patents

VitalNext Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2016282923-A1 Compositions and methods for the treatment of malnutrition Active 26-Jun-2015
AU-2016282923-B2 Compositions and methods for the treatment of malnutrition Active 26-Jun-2015
CA-2987364-A1 Compositions and methods for the treatment of malnutrition Active 26-Jun-2015
CA-2987364-C Compositions and methods for the treatment of malnutrition Active 26-Jun-2015
EP-3313207-A1 Compositions and methods for the treatment of malnutrition Active 26-Jun-2015 A61K38/1709
To view VitalNext’s complete patent history, request access »

VitalNext Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VitalNext Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
LRM Venture Capital Minority
Oost NL Venture Capital Minority
Samenwerkingsverband Noord-Nederland Government Minority
Hanzepoort Venture Capital Minority
Lakefront Biotherapeutics Corporation Minority
You’re viewing 5 of 8 investors. Get the full list »

VitalNext FAQs

  • When was VitalNext founded?

    VitalNext was founded in 2013.

  • Where is VitalNext headquartered?

    VitalNext is headquartered in Leiden, Netherlands.

  • What is the size of VitalNext?

    VitalNext has 1 total employees.

  • What industry is VitalNext in?

    VitalNext’s primary industry is Other Consumer Non-Durables.

  • Is VitalNext a private or public company?

    VitalNext is a Private company.

  • What is VitalNext’s current revenue?

    The current revenue for VitalNext is .

  • How much funding has VitalNext raised over time?

    VitalNext has raised $1.98M.

  • Who are VitalNext’s investors?

    LRM, Oost NL, Samenwerkingsverband Noord-Nederland, Hanzepoort, and Lakefront Biotherapeutics are 5 of 8 investors who have invested in VitalNext.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process